Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2005-01-24
2010-02-23
Lucas, Zachariah (Department: 1648)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S139100, C424S141100, C424S159100, C530S387100, C530S387900, C530S388100, C530S388300, C530S389400
Reexamination Certificate
active
07666420
ABSTRACT:
The inventive composition comprises at least one type of antibody selected in a group (i) of anti-Env-SU MSRV/HERV-W antibodies or in a group of anti-TLR4 antibodies specifically linkable with the soluble fraction of an Env protein of MSRV/HERV-W or to a TLR4 receptor of the soluble fraction of the Env protein of MSRV/HERV-W.
REFERENCES:
patent: WO 95/21256 (1995-08-01), None
patent: WO 99/67395 (1999-12-01), None
patent: WO 01/16171 (2001-03-01), None
patent: WO 01/31021 (2001-05-01), None
patent: WO 03/035110 (2003-05-01), None
Wang et al. “Involvement of CD14 and Toll-Like Receptors in Activation of Human Monocytes byAspergillus fumigatusHyphae,” Infection and Immunity, vol. 69 No. 4, pp. 2402-2406 (Apr. 2001).
Abaza et al., “Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: Demonstration with region 94-100 (antigenic site 3) of myoglobin ,” Journal of Protein Chemistry, vol. 11 No. 5, pp. 433-444 (Oct. 1992).
Antony et al., “Comparative Expression of Human Endogenous Retrovirus-W Genes in Multiple Sclerosis,” AIDS Research and Human Retroviruses, vol. 23 No. 10, pp. 1251-1256 (2007).
Antony et al., “The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes.,” Journal of Immunology, vol. 179 No. 2, pp. 1210-1224 (Jul. 2007).
Kim et al., “Human Endogenous Retrovirus HERV-W Family: Chromosomal Localization, Identification, and Phylogeny,” AIDS Research and Human Retroviruses, vol. 17 No. 7, pp. 643-648 (2001).
Riffkin et al., “A single amino-acid change between the antigenically different extracellular serine proteases V2 and B2 fromDichelobacter nodosus,” Gene, vol. 167 No. 1-2, pp. 279-283 (Dec. 1995).
Conrad, Bernard et al. “A Human Endogenous Retroviral Superantigen as Candidate Autoimmune Gene in Type 1 Diabetes,”Cell, vol. 90, pp. 303-313, Jul. 25, 1997.
Perron, H. et al. “Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis,”Proc. National Academy of Science USA, vol. 94, pp. 7583-7588, Jul. 1997.
Deb-Rinker, Paromita et al. “Molecular Characterization of a MSRV-like Sequence Identified by RDA from Monozygotic Twin Pairs Discordant for Schizophrenia,”Genomics, vol. 61, pp. 133-144, 1999.
Perron, H. et al. “Isolation of a Retrovirus from Patients with Multiple Sclerosis,”The Lancet, vol. 337, pp. 862 -863, Apr. 6, 1991.
Blond, Jean-Luc et al. “Molecular Characterization and Placental Expression of HERV-W, a New Human Endogenous Retrovirus Family,”Journal of Virology, vol. 73, No. 2, pp. 1175-1185, Feb. 1999.
Perron, Herve et al. “Particle-associated retroviral RNA and tandem RGH/HERV-W copies on human chromosome 7q: possible components of a ‘chain-reaction’ triggered by infectious agents in multiple sclerosis?,”Journal of NeuroVirology, vol. 16, Supplement 2, pp. S67-S75, 2000.
Dolei, A. et al. “Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients,”Neurology, vol. 58, pp. 471-473, 2002.
Garson, J. A. et al. “Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis,”The Lancet, vol. 351, p. 33, Jan. 3, 1998.
Olsson, Patrik et al. “Retroviral RNA Related to ERV9/MSRV in a Human Serum: A New Sequence Variant,”Aids Research and Human Retroviruses, vol. 15, No. 6, pp. 591-593, 1999.
Sotgiu, S. et al. “Multiple sclerosis-associated retrovirus and MS prognosis; an observational study,”Neurology, vol. 59, pp. 1071-1073, 2002.
Perron, H. et al. “Multiple Sclerosis Retrovirus Particles and Recombinant Envelope Trigger an Abnormal Immune Response in Vitro, by Inducing Polyclonal Vβ16 T-Lymphocyte Activation,”Virology, vol. 287, pp. 321-332, 2001.
Firouzi, R. et al. “Multiple sclerosis-associated retrovirous particles cause T-lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model,”Journal of NeuroVirology, vol. 9, pp. 79-93, 2003.
Lin, A. et al. “The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6,”Schizophrenia Research, vol. 32, pp. 9-15, 1998.
Stevens, Janice R. “Neuropathology of Schizophrenia,”Arch. Gen. Psychiatry, vol. 39, pp. 1131-1139, Oct. 1982.
Karlsson, Hakan et al. “Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia,”PNAS, vol. 98, No. 8, pp. 4634-4639, Apr. 10, 2001.
Perron, H. et al. “Microbial Agents Triggering Endogenous Retroviruses within Genetic Susceptibility Loci Resulting in Expression of Superantigen and Gliotoxic Molecules: a plausible ‘Immunovirogenetic’ Cascade Causing Multiple Sclerosis,”Mod. Asp. Immunobiol, vol. 1, No. 5, pp. 198-203, 2001.
Liu, Yuxin et al. “Dextromethorphan Protects Dopaminergic Neurons against Inflammation-Mediated Degeneration through Inhibition of Microglial Activation,”Journal of Pharmacology and Experimental Therapeutics, vol. 305, pp. 212-218, 2003.
Morimoto, Kiyoshi et al. “Acute Neuroinflammation Exacerbates Excitotoxicity in Rat Hippocampus in Vivo,”Experimental Neurology, vol. 177, pp. 95-104, 2002.
Stoll, G. “Inflammatory cytokines in the nervous system: multifunctional mediators in autoimmunity and cerebral ischemia,”Rev. Neurol, vol. 158, No. 10, pp. 887-891, 2002.
Guillemin, Gilles J. et al. “Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease,”Redox Report, vol. 7, No. 4, 2002.
Kim, Eun Joo et al. “Neuroprotective Effects of Prostaglandin E2or cAMP Against Microglial and Neuronal Free Radical Mediated Toxicity Associated With Inflammation,”Journal of Neuroscience Research, vol. 70, pp. 97-107, 2002.
Kim, Won-Gon. “Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia,”Journal of Neuroscience, vol. 20, pp. 6309-6316, Aug. 15, 2000.
Klein, Christine et al. “Association Studies of Parkinson's Disease andparkinPolymorphisms,” Letters to the Editor:Annals of Neurology, vol. 48, No. 1, pp. 126-127, Jul. 2000.
Licinio, J. et al. “The Role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection,”Molecular Psychiatry, vol. 4, pp. 317-327, 1999.
Cotter, Robin et al. “Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity,”Journal of Luekocyte Biology, vol. 65, pp. 416-427, Apr. 1999.
Heese, Klaus. “Inflammatory Signals Induce Neurotrophin Expression in Human Microglial Cells,”Journal of Neurochemistry, vol. 70, No. 2, pp. 699-707, 1998.
Sasser, L. B. et al. “Subchronic Toxicity Evaluation of Lewisite in Rats,”Journal of Toxicology and Environmental Health, vol. 47, pp. 321-334, 1996.
Chao, Chun C. “Interleukin-1 and Tumor Necrosis Factor-α Synergistically Mediate Neurotoxicity: Involvement of Nitric Oxide and of N-Methyl-D-aspartate Receptors,”Brain, Behavior and Immunity, vol. 9, pp. 355-365, 1995.
Chao, Chun C. et al. “Tumor Necrosis Factor-Alpha Potentiates Glutamate Neurotoxicity in Human Fetal Brain Cell Cultures,”Dev. Neurosci., vol. 16, pp. 172-179, 1994.
Bal-Price, Anna et al. “Inflammatory Neurodegeneration Mediated by Nitric Oxide from Activated Glia-Inhibition Neuronal Respiration, Causing Glutamate Release and Excitotoxicity,”Journal of Neuroscien
Jouvin-Marche Evelyne
Marche Patrice
Perron Herve
Rolland Alexandre
Biomerieux
Institut National de la Sante et de la Recherche Medicale
Lucas Zachariah
Oliff & Berridg,e PLC
LandOfFree
Composition for treating pathology associated with MSRV/HERV-W does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for treating pathology associated with MSRV/HERV-W, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for treating pathology associated with MSRV/HERV-W will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4201073